Veeda Starts 2nd new facility at Ahmedabad

Veeda Clinical Research today started its second facility at Ahmedabad. Spread over 25,000 square feet, the facility will house a bio-analytical laboratory together with an administrative office.



Veeda has plans to expand the clinical facility across two phases which would see the bed capacity rise to around 200. Work on the first phase is likely to be completed by December and would house around 100-120 beds. Further expansion would depend on regulatory approvals, the company said. It, however, did not disclose the investment figures.


The new facility has been designed using GLP and GMP requirements and the laboratory will be capable of housing up to 26 LC/MS/MS machines. Besides, there would be dedicated areas such as high-end sample processing, light sensitive area, special care area where controlled conditions can be maintained for molecule specific requirements. "Additionally, the compartmental lab design will be helpful to maintain confidentiality and cross contamination.This will enhance our capability of handling tricky assays like hormonal, oncology, antiretroviral, endogenous and chiral assays and clinically difficult samples like tissues, patient and infectious samples respectively", Veeda said in a statement, The administrative office will house the finance, human resources, administration, information technology, business development departments as well as key management members. The company now has units in Ahmedabad, UK, Belgium and Germany.


By 2012, analysts project that more than 65 per cent of all FDA regulated trials will take place outside the United States. This is reflected in the Indian biotechnology market, which is expected to grow at a compounded annual growth rate of 30 per cent, and the Indian CRO market, which is expected to see growth of 49 per cent annually.

Source:http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=350